MiSight® 1 day
MiSight® 1 day is a safe and well-tolerated soft contact lens. It has the strongest and longest research record of any lens used for myopia control. Doctors often recommend it as a first choice for both correcting and slowing myopia.
MiSight® 1 day is also the first and only lens approved by the U.S. FDA for myopia control. Research has shown it to be safe, effective, and well accepted by children with myopia. Two clinical trials, lasting two and three years, proved its benefits. Published results now cover up to six years, with reports extending to seven years, giving MiSight® the most complete dataset of any myopia control soft lens.
asdf
Visit the MiSight® 1 day website.
MiSight® 1 day Information
Product disclaimer
FDA Indications for use (US only): MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters (spherical equivalent) with ≤0.75 diopters of astigmatism. The lens is to be discarded after each removal.
Availability of interventions with regulatory indications to slow progression of myopia varies by country. CooperVision does not endorse off label prescribing of interventions for myopia control.